The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Genetic and Pharmacological Inhibition of Galectin-3 Prevents Cardiac Remodeling by Interfering With Myocardial Fibrogenesis
Open accessAbstract
Background—: Galectin-3 has been implicated in the development of organ fibrosis. It is unknown whether it is a relevant therapeutic target in cardiac remodeling and heart failure. Methods and Results—: Galectin-3 knock-out and wild-type mice were subjected to angiotensin II infusion (2.5 µg/kg for 14 days) or transverse aortic constriction for 28 days to provoke cardiac remodeling. The efficacy of the galectin-3 inhibitor N-acetyllactosamine was evaluated in TGR(mREN2)27 (REN2) rats and in wild-type mice with the aim of reversing established cardiac remodeling after transverse aortic constriction. In wild-type mice, angiotensin II and transverse aortic constriction perturbations caused left-ventricular (LV) hypertrophy, decreased fractional shortening, and increased LV end-diastolic pressure and fibrosis ( P <0.05 versus control wild type). Galectin-3 knock-out mice also developed LV hypertrophy but without LV dysfunction and fibrosis ( P =NS). In REN2 rats, pharmacological inhibition of galectin-3 attenuated LV dysfunction and fibrosis. To elucidate the beneficial effects of galectin-3 inhibition on myocardial fibrogenesis, cultured fibroblasts were treated with galectin-3 in the absence or presence of galectin-3 inhibitor. Inhibition of galectin-3 was associated with a downregulation in collagen production (collagen I and III), collagen processing, cleavage, cross-linking, and deposition. Similar results were observed in REN2 rats. Inhibition of galectin-3 also attenuated the progression of cardiac remodeling in a long-term transverse aortic constriction mouse model. Conclusions—: Genetic disruption and pharmacological inhibition of galectin-3 attenuates cardiac fibrosis, LV dysfunction, and subsequent heart failure development. Drugs binding to galectin-3 may be potential therapeutic candidates for the prevention or reversal of heart failure with extensive fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cardiac Fibroblast: The Renaissance Cell
Souders, C. A., Bowers, S. L. K., & Baudino, T. A. (2009) · Circulation Research · doi:10.1161/circresaha.109.209809 · Cited by 984
Sharma, U. C., Pokharel, S., van Brakel, T. J., van Berlo, J. H., Cleutjens, J. P. M., Schroen, B., André, S., Crijns, H. J. G. M., Gabius, H. J., Maessen, J., et al. (2004) · Circulation · doi:10.1161/01.cir.0000147181.65298.4d · Cited by 947
ECM remodeling in hypertensive heart disease
Berk, B. C., Fujiwara, K., & Lehoux, S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31044 · Cited by 902
Galectins: structure, function and therapeutic potential
Yang, R.-Y., Rabinovich, G. A., & Liu, F.-T. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000719 · Cited by 862
Pacher, P., Nagayama, T., Mukhopadhyay, P., Bátkai, S., & Kass, D. A. (2008) · Nature Protocols · doi:10.1038/nprot.2008.138 · Cited by 734 · cited 1×
“Cardiac function was studied with echocardiography and hemodynamic measurement as described previously.(15,16) Immunohistochemical analyses were performed, and collagen digestibility was determined.”
MethodGalectin-3 regulates myofibroblast activation and hepatic fibrosis
Henderson, N. C., Mackinnon, A. C., Farnworth, S. L., Poirier, F., Russo, F. P., Iredale, J. P., Haslett, C., Simpson, K. J., & Sethi, T. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511167103 · Cited by 625
de Boer, R. A., Lok, D. J. A., Jaarsma, T., van der Meer, P., Voors, A. A., Hillege, H. L., & van Veldhuisen, D. J. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.538080 · Cited by 592
Self-citationGalectin-3, a Marker of Cardiac Fibrosis, Predicts Incident Heart Failure in the Community
Ho, J. E., Liu, C., Lyass, A., Courchesne, P., Pencina, M. J., Vasan, R. S., Larson, M. G., & Levy, D. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.04.053 · Cited by 589
van Kimmenade, R. R., Januzzi, J. L., Ellinor, P. T., Sharma, U. C., Bakker, J. A., Low, A. F., Martinez, A., Crijns, H. J., MacRae, C. A., Menheere, P. P., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.061 · Cited by 567
Galectin-3 Expression and Secretion Links Macrophages to the Promotion of Renal Fibrosis
Henderson, N. C., Mackinnon, A. C., Farnworth, S. L., Kipari, T., Haslett, C., Iredale, J. P., Liu, F.-T., Hughes, J., & Sethi, T. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070726 · Cited by 562 · cited 2×
“Male Gal3-KO mice were generated and bred at the Jackson Laboratory (Bar Harbor, ME) as described previously.(2,8,9) Age-matched male transgene–negative wild-type (WT) littermates were used as controls.”
BackgroundMethodGalectin-3: A Novel Mediator of Heart Failure Development and Progression
de Boer, R. A., Voors, A. A., Muntendam, P., van Gilst, W. H., & van Veldhuisen, D. J. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfp097 · Cited by 524
Self-citationMethods in cardiomyocyte isolation, culture, and gene transfer
Louch, W. E., Sheehan, K. A., & Wolska, B. M. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.06.012 · Cited by 497
Lok, D. J. A., Van Der Meer, P., de la Porte, P. W. B.-A., Lipsic, E., Van Wijngaarden, J., Hillege, H. L., & van Veldhuisen, D. J. (2010) · Clinical Research in Cardiology · doi:10.1007/s00392-010-0125-y · Cited by 465
Self-citationTargeted Disruption of the Galectin-3 Gene Results in Attenuated Peritoneal Inflammatory Responses
Hsu, D. K., Yang, R.-Y., Pan, Z., Yu, L., Salomon, D. R., Fung-Leung, W.-P., & Liu, F.-T. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64975-9 · Cited by 428
Self-citationUsher, M. G., Duan, S. Z., Ivaschenko, C. Y., Frieler, R. A., Berger, S., Schütz, G., Lumeng, C. N., & Mortensen, R. M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41080 · Cited by 383
The fibrosis marker galectin‐3 and outcome in the general population
de Boer, R. A., van Veldhuisen, D. J., Gansevoort, R. T., Muller Kobold, A. C., van Gilst, W. H., Hillege, H. L., Bakker, S. J. L., & van der Harst, P. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02476.x · Cited by 376
Self-citationIntramyocardial Fibroblast Myocyte Communication
Kakkar, R., & Lee, R. T. (2010) · Circulation Research · doi:10.1161/circresaha.109.207456 · Cited by 333
Shah, R. V., Chen-Tournoux, A. A., Picard, M. H., van Kimmenade, R. R. J., & Januzzi, J. L. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq091 · Cited by 326
Liu, Y.-H., D'Ambrosio, M., Liao, T.-D., Peng, H., Rhaleb, N.-E., Sharma, U., André, S., Gabius, H.-J., & Carretero, O. A. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00747.2008 · Cited by 269
Myllyharju, J. (2008) · Annals of Medicine · doi:10.1080/07853890801986594 · Cited by 267
van der Meer, P., Lipsic, E., Henning, R. H., Boddeus, K., van der Velden, J., Voors, A. A., van Veldhuisen, D. J., van Gilst, W. H., & Schoemaker, R. G. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.03.044 · Cited by 257
Self-citationDemotte, N., Wieërs, G., Van Der Smissen, P., Moser, M., Schmidt, C., Thielemans, K., Squifflet, J.-L., Weynand, B., Carrasco, J., Lurquin, C., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0761 · Cited by 179
Badenhorst, D. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00733-2 · Cited by 166
Rockman, H. A., Wachhorst, S. P., Mao, L., & Ross, J. (1994) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1994.266.6.h2468 · Cited by 160
Microassay for the Assessment of Low Levels of Hydroxyproline
Creemers, L. B., Jansen, D. C., van Veen-Reurings, A., van den Bos, T., & Everts, V. E. (1997) · BioTechniques · doi:10.2144/97224bm19 · Cited by 156
The type of collagen cross-link determines the reversibility of experimental skin fibrosis.
van der Slot-Verhoeven, A. J., van Dura, E. A., Attema, J., Blauw, B., DeGroot, J., Huizinga, T., Zuurmond, A., & Bank, R. (2005) · Biochimica et Biophysica Acta · doi:10.1016/j.bbadis.2005.02.007 · Cited by 155
Self-citationKolatsi‐Joannou, M., Price, K. L., Winyard, P. J. D., & Long, D. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018683 · Cited by 152
Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27
Lee, M. A., Böhm, M., Paul, M., Bäder, M., Ganten, U., & Ganten, D. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.270.6.e919 · Cited by 132
Nwogu, J. I., Geenen, D., Bean, M., Brenner, M. C., Huang, X., & Buttrick, P. M. (2001) · Circulation · doi:10.1161/hc4301.097193 · Cited by 131
Early detection of myocardial dysfunction and heart failure
de Couto, G., Ouzounian, M., & Liu, P. P. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.51 · Cited by 129
Low Micromolar Inhibitors of Galectin‐3 Based on 3′‐Derivatization ofN‐Acetyllactosamine
Sörme, P., Qian, Y., Nyholm, P., Leffler, H., & Nilsson, U. J. (2002) · ChemBioChem · Cited by 106
Breakfast Cereals and Risk of Heart Failure in the Physicians' Health Study I
Djoussé, L., & Gaziano, J. M. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.19.2080 · Cited by 92
de Boer, R. A., Pokharel, S., Flesch, M., van Kampen, D. A., Suurmeijer, A. J. H., Boomsma, F., van Gilst, W. H., van Veldhuisen, D. J., & Pinto, Y. M. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0579-3 · Cited by 60
Conformational Differences in Liganded and Unliganded States of Galectin-3
Umemoto, K., Leffler, H., Venot, A. P., Valafar, H., & Prestegard, J. H. (2003) · Biochemistry · doi:10.1021/bi026671m · Cited by 57
Characterization of a rat alveolar macrophage cell line that expresses a functional mannose receptor
Lane, K. B., Egan, B. S., Vick, S., Abdolrasulnia, R., & Shepherd, V. L. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.64.3.345 · Cited by 47
Activation of Liver X Receptors with T0901317 Attenuates Cardiac Hypertrophy in vivo
Kuipers, I., Li, J., Vreeswijk‐Baudoin, I., Koster, J., van der Harst, P., Silljé, H. H. W., Kuipers, F., van Veldhuisen, D. J., van Gilst, W. H., & de Boer, R. A. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq109 · Cited by 45
Self-citationHeart failure-associated anemia: bone marrow dysfunction and response to erythropoietin
Ruifrok, W.-P. T., Qian, C., Silljé, H. H. W., van Goor, H., van Veldhuisen, D. J., van Gilst, W. H., & de Boer, R. A. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0710-6 · Cited by 26
Self-citationFielitz, J., Philipp, S., Herda, L. R., Schuch, E., Pilz, B., Schubert, C., Günzler, V., Willenbrock, R., & Regitz‐Zagrosek, V. (2006) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2006.10.006 · Cited by 20
Cited by
Frangogiannis, N. G. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa324 · Cited by 1,229
Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities
Frangogiannis, N. G. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.07.001 · Cited by 841
Murphy, S. P., Kakkar, R., McCarthy, C. P., & Januzzi, J. L. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.01.014 · Cited by 738
Functions and mechanisms of microglia/macrophages in neuroinflammation and neurogenesis after stroke
Xiong, X.-Y., Liu, L., & Yang, Q.-W. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.05.001 · Cited by 701
Chow, S. L., Maisel, A. S., Anand, I., Bozkurt, B., de Boer, R. A., Felker, G. M., Fonarow, G. C., Greenberg, B., Januzzi, J. L., Kiernan, M. S., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000490 · Cited by 601
Self-citation
Metadata
- Authors
- Yu, L., Ruifrok, W. P. T., Meissner, M., Bos, E. M., van Goor, H., Sanjabi, B., van der Harst, P., Pitt, B., Goldstein, I. J., Koerts, J. A., van Veldhuisen, D. J., Bank, R. A., van Gilst, W. H., Silljé, H. H. W., & de Boer, R. A.
- Venue
- Circulation: Heart Failure
- Published
- 2013-01
- Volume
- 6
- Issue
- 1
- Pages
- 107-117
- ISSN
- 1941-3289 (ISSN-L)
- 1941-3297
- OpenAlex
- W2161321429
- Cited by
- 435
- References
- 38
- FWCI
- 18.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.